|
Goicoechea I, Puig N, Cedena MT, Burgos L, Cordon L, Vidriales MB, Flores-Montero J, Gutierrez NC, Calasanz MJ, Ramos MM, Lara-Astiaso D, Vilas-Zornoza A, Alignani D, Rodriguez I, Sarvide S, Alameda D, Garces JJ, Rodriguez S, Fresquet V, Celay J, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Rios R, Martin-Sanchez J, Martinez-Martinez R, Sarra J, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Martinez-Climent JA, Orfao A, Rosinol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel J, Paiva B. Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma. Blood. 2021 Jan 7;137(1):49-60. doi: 10.1182/blood.2020006731. PubMed PMID: 32693406.
AÑO: 2021; IF: 25.476
|
32693406
|
Richardson E, Garcia-Bernal D, Calabretta E, Jara R, Palomo M, Baron RM, Yanik G, Fareed J, Vlodavsky I, Iacobelli M, Diaz-Ricart M, Richardson PG, Carlo-Stella C, Moraleda JM. Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes. Expert Opin Ther Targets. 2021 Jun;25(6):423-433. doi: 10.1080/14728222.2021.1944101. Epub 2021 Jun 25. PubMed PMID: 34167431.
AÑO: 2021; IF: 6.797
|
|
Novelli S., Bento L., Garcia I., Prieto L., López L., Gutierrez G., Hernani R., Pérez A., Esquirol A., Solano C., Bastos M., Dorado N., Rodríguez N., Rodríguez G., Piñana J.L., Montoro J., Herrera P., Luna A., Parody R., Martín C., García E., López O., Heras I., Zanabili J., Moraleda J.M., Yañez L., Gutierrez A., Zudaire T., Córdoba R., Varela R., Ferra C., Martínez J., Martínez C., Gonzalez-Barca E., Martino R., Caballero D. Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers. Transplantation and Cellular Therapy. June 2021. 27:493.e1-493.e8. 10.1016/j.jtct.2021.03.014
AÑO: 2021; IF: 0.0
|
|
Noriega D.C., Ardura F., Hernández-Ramajo R., Martín-Ferrero M.Á., Sánchez-Lite I., Toribio B., Alberca M., García V., Moraleda J.M., González-Vallinas M., Sánchez A., García-Sancho J. Treatment of Degenerative Disc Disease with Allogeneic Mesenchymal Stem Cells: Long-term Follow-up Results. Transplantation. 1 February 2021. 105:E25-E27. 10.1097/TP.0000000000003471
AÑO: 2021; IF: 5.385
|
|
Garcia-Bernal D, Palomo M, Martinez CM, Millan-Rivero JE, Garcia-Guillen AI, Blanquer M, Diaz-Ricart M, Sackstein R, Carreras E, Moraleda JM. Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease. J Cell Mol Med. 2020 Jul;24(14):8031-8044. doi: 10.1111/jcmm.15434. Epub 2020 Jun 10. PubMed PMID: 32519822; PubMed Central PMCID: PMC7348164.
AÑO: 2020; IF: 5.31
|